国产头孢吡肟治疗中重度下呼吸道感染安全、有效。
Domestic cefepime is effective and safe in the treatment of moderate to severe lower respiratory infections.
对头孢他啶，头孢吡肟和阿米卡星的耐药率在65%以上；
The drug resistance rate of ceftazidime, cefepime and amikacin were over 65%.
目的探讨头孢吡肟治疗重型肝炎肝移植术后细菌感染的疗效。
Objective To evaluate the efficacy and safety of cefepime in the treatment of bacterial infection in severe hepatitis patients after liver transplantation.
国产和进口盐酸头孢吡肟组不良反应发生率分别为3.0%和6.2%。
The rates of adverse reactions of domestic and imported cefepime were 3.0% and 6.2%.
结论：国产头孢吡肟治疗中重度呼吸道感染患者疗效可靠，安全性较好。
Conclusion: Domestic cefepime has reliable curative effect and good safety in the treatment of moderate to severe respiratory infection.
目的：评价头孢吡肟对老年人院内获得性呼吸道感染的临床疗效和安全性。
AIM: to evaluate the efficacy and safety of cefepime in treating hospital acquired respiratory tract infections in elderly.
目的研究汉族健康志愿者单剂量静脉滴注盐酸头孢吡肟后的药物代谢动力学。
Objective To study the pharmacokinetics of cefepime after a single intravenous administration in Han healthy Chinese volunteers.
目的：观察头孢吡肟对重症监护病房(icu)院内感染细菌的体外抗菌活性。
AIM: to observe antibacterial activity of cefepime to bacteria of intensive care unit (ICU) nosocomial infection in vitro.
到那时候，FDA将通知医疗供应商考虑安全标签和荟萃分析中描述的头孢吡肟疗法的风险获益。
Until that time, healthcare providers are advised to consider the risks and benefits of cefepime therapy as described in the safety labeling and the meta-analysis.
结论：头孢吡肟抗菌谱广，疗效好，不良反应轻微，对治疗老年细菌性下呼吸道感染是一个安全、有效的抗感染经验治疗药物。
Conclusion: Cefepime has a good therapeutic efficacy and safety in the treatment of aged patients with bacterial lower respiratory infections.
方法：我院2003年6 ~7月使用其它抗生素治疗无效的中重度肺炎患儿11例，给予头孢吡肟治疗，观察疗效和不良反应。
Method: 11 cases of pneumonia whose 6-7 month treatments with other antibiotics turned out to be ineffective in 2003 were treated with cefepime.
方法：我院2003年6 ~7月使用其它抗生素治疗无效的中重度肺炎患儿11例，给予头孢吡肟治疗，观察疗效和不良反应。
Method: 11 cases of pneumonia whose 6-7 month treatments with other antibiotics turned out to be ineffective in 2003 were treated with cefepime.
应用推荐